Lunaphore has developed a next-generation tissue diagnostics platform for the analysis and classification of tumors and other solid tissues. Based on a proprietary microfluidic chip technology and a bench top device, the platform offers customers unprecedented speed, accuracy and flexibility.
Lunaphore’s unique solution meets today’s needs, where medicine is becoming more personalized and whole panels of biomarkers play an increasing role.
Lunaphore in the News:
Jobs at Lunaphore